» Articles » PMID: 9058310

Primary Sclerosing Cholangitis in Japan--analysis of 192 Cases

Overview
Journal J Gastroenterol
Specialty Gastroenterology
Date 1997 Feb 1
PMID 9058310
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Primary sclerosing cholangitis is very rare in Japan. The aim of the present study was to identify the characteristics of such patients in Japan. A questionnaire was sent to the members of the Japanese Society of Gastroenterology and responses for 192 cases were analyzed. There was male predominancy (61%), and two peaks in the age distribution at diagnosis (20-30 years and 50-70 years). Bile duct damage was mainly intra + extrahepatic (69%) versus intrahepatic (17%) or extrahepatic (14%). The incidences of eosinophilia and positivity for anti-nuclear antibody were 27% and 30%, respectively. The incidence of associated inflammatory bowel disease was 21% (38 ulcerative colitis and 2 Crohn's disease). Chronic pancreatitis, gallstones, and biliary cancers occurred in 15%, 12%, and 4%, respectively, of the 192 patients. Patients less than 40 years of age had a higher incidence than the patients 40 years old or more of damage intra + extrahepatic bile ducts (89% vs 56%) and of associated ulcerative colitis (36% vs 9%), whereas the incidence of chronic pancreatitis was lower in patients aged less than 40 years (4%). The characteristics of patients with primary sclerosing cholangitis in Japan differ from those in other countries in regard to age distribution and the incidence of complications, and at least two different groups of patients seem to exist in terms of the degree of bile duct damage and the incidence of complications.

Citing Articles

Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.

Catanzaro E, Gringeri E, Burra P, Gambato M Cancers (Basel). 2023; 15(20).

PMID: 37894314 PMC: 10604939. DOI: 10.3390/cancers15204947.


Risk factors for the postoperative recurrence of ulcerative colitis-associated colorectal cancer.

Horio Y, Uchino M, Igeta M, Nagano K, Kusunoki K, Kuwahara R Int J Colorectal Dis. 2023; 38(1):113.

PMID: 37138034 DOI: 10.1007/s00384-023-04410-z.


The microbiota and the gut-liver axis in primary sclerosing cholangitis.

Hov J, Karlsen T Nat Rev Gastroenterol Hepatol. 2022; 20(3):135-154.

PMID: 36352157 DOI: 10.1038/s41575-022-00690-y.


Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population.

Nardelli M, Bittencourt P, Cancado G, Faria L, Villela-Nogueira C, Rotman V Can J Gastroenterol Hepatol. 2021; 2021:7746401.

PMID: 34805028 PMC: 8604588. DOI: 10.1155/2021/7746401.


Elective staged proctocolectomy and living donor liver transplantation for colon cancer with sclerosing cholangitis-related ulcerative colitis: a case report.

Miyagi Y, Kinjo T, Yoshizumi T, Harada N, Arakaki S, Kinjo T Surg Case Rep. 2020; 6(1):278.

PMID: 33130979 PMC: 7604274. DOI: 10.1186/s40792-020-01059-6.


References
1.
Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, JENSSEN E, Kolmannskog F . Risk factors in primary sclerosing cholangitis. J Hepatol. 1994; 21(6):1061-6. DOI: 10.1016/s0168-8278(05)80618-x. View

2.
Wiesner R, Grambsch P, Dickson E, Ludwig J, MacCarty R, Hunter E . Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 1989; 10(4):430-6. DOI: 10.1002/hep.1840100406. View

3.
Martin F, Rossi R, Nugent F, Scholz F, Jenkins R, Lewis W . Surgical aspects of sclerosing cholangitis. Results in 178 patients. Ann Surg. 1990; 212(4):551-6; discussion 556-8. PMC: 1358296. DOI: 10.1097/00000658-199010000-00017. View

4.
Larusso N, Wiesner R, Ludwig J, MacCarty R . Current concepts. Primary sclerosing cholangitis. N Engl J Med. 1984; 310(14):899-903. DOI: 10.1056/NEJM198404053101407. View

5.
Shiraoku H, Hokamura M, Sagara K, Fujiyama S . A case of primary sclerosing cholangitis. Gastroenterol Jpn. 1985; 20(4):368-73. DOI: 10.1007/BF02774748. View